Veeva’s vice president of global business consulting discusses recent trends in HCP access and how the pharma industry is reacting.
![HCP Access Drops but Connected Field Engagement Breaks Through: Q&A with Dan Rizzo](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
Veeva’s vice president of global business consulting discusses recent trends in HCP access and how the pharma industry is reacting.